Mitchell Grayson, MD
mitchmd.bsky.social
Mitchell Grayson, MD
@mitchmd.bsky.social
Physician-scientist studying the interaction of respiratory viral infections and allergic disease.
Reposted by Mitchell Grayson, MD
Did you read the article we posted on Tuesday? Have thoughts to share? We welcome correspondence. Share yours here: annals@acaai.org
December 4, 2025 at 3:04 PM
Reposted by Mitchell Grayson, MD
A striking finding was the higher prevalence of asthma in women than in men in Latin America, coinciding with reports pointing to possible hormonal and biological factors, and exposure differences to occupational and environmental risk factors. https://loom.ly/v3yC7H4
December 2, 2025 at 3:06 PM
Reposted by Mitchell Grayson, MD
We are grateful for our readers and authors, reviewers and editors. We are grateful for more than 80 years of publication, as we document our experience, discoveries, our growth in allergy, asthma and immunology. Happy Thanksgiving from Annals!
November 27, 2025 at 5:05 PM
Figured if we are headed back to the 1890’s (politically speaking), I should have a chapeau that was appropriate.

Happy Thanksgiving!
November 26, 2025 at 11:56 PM
Reposted by Mitchell Grayson, MD
The December issue of Annals of Allergy, Asthma & Immunology is here -- dedicated to Food Protein Induced Enterocolitis Syndrome (FPIES). Read and learn more at www.annallergy.org/current And oh, what a great holiday cover image (see below)! @annalsacaai.bsky.social #MedSky #allergy #immunology
November 24, 2025 at 1:18 PM
Reposted by Mitchell Grayson, MD
There is a lack of diversity and representation of historically marginalized groups in current clinical research. The primary objective for this study was to evaluate recruitment and retention strategies for patients historically marginalized in asthma clinical trials. https://loom.ly/sVcJ-vM

November 20, 2025 at 3:04 PM
Reposted by Mitchell Grayson, MD
One of the first-line options for long term prophylaxis in HAE patients is lanadelumab, a fully human monoclonal antibody inhibiting plasma kallikrein. The authors report findings from 2 prospective, noninterventional, multicenter phase 4 studies. Learn more: https://loom.ly/gMx757w
November 18, 2025 at 8:10 PM
Reposted by Mitchell Grayson, MD
Ready to submit an article? Share your expertise and submit it here: https://loom.ly/uBd7yU4
Editorial Manager®
Full-Function Web-Enabled Manuscript Submission and Tracking System for Peer Review
www.editorialmanager.com
November 13, 2025 at 3:05 PM
Reposted by Mitchell Grayson, MD
This review discusses drug hypersensitivity reactions in mastocytosis, focusing on the most frequent drug triggers and their management. A history-driven, evidence-based approach allows most patients to be treated effectively without unnecessary drug avoidance. https://loom.ly/nlkd5RY
November 11, 2025 at 3:06 PM
Reposted by Mitchell Grayson, MD
Chronic rhinosinusitis (CRS) is a common condition evaluated by the allergist-immunologist. Here are 10 things you should know about this common and important condition. https://loom.ly/JT_dPHQ
November 6, 2025 at 3:06 PM
Reposted by Mitchell Grayson, MD
Several new agents have received Food and Drug Administration approval, expanding therapeutic options for patients. These innovations represent a shift toward personalized atopic dermatitis management. Learn more: https://loom.ly/hszCE8g
November 4, 2025 at 3:05 PM
Reposted by Mitchell Grayson, MD
Do you want to write an article for Annals? Here are our guidelines: www.annallergy.org/content/auth...
Information for Authors: Annals of Allergy, Asthma & Immunology
www.annallergy.org
October 30, 2025 at 2:20 PM
Reposted by Mitchell Grayson, MD
Earn CME credit with Annals' CME online exams! Read an article in Annals, then take an exam for CME credit! Learn more: https://loom.ly/h7upvqk
Earn CME with Annals
Annals of Allergy, Asthma & Immunology offers the opportunity to earn CME through some of its articles. Learn more.
www.annallergy.org
October 23, 2025 at 2:05 PM
Reposted by Mitchell Grayson, MD
Did you know Annals features collections of articles based on topic? Asthma, Clinical Practice, Drug Allergy, Immunodeficiency, Rhinosinusitis, and more! Access them in the Collections area about halfway down the Annals homepage: https://loom.ly/qDK5bcY
Collections
Read more about Collections at Annals of Allergy, Asthma & Immunology
www.annallergy.org
October 21, 2025 at 8:30 PM
Reposted by Mitchell Grayson, MD
How do you systematically synthesize the benefits and harms of triple therapy (ICS/LABA/long-acting muscarinic antagonists) compared with dual therapy (ICS/LABA) for asthma management across key subpopulations? Find out here: https://loom.ly/C3UpA6E
Triple therapy vs dual inhaler therapy for moderate-to-severe asthma
An updated systematic review and meta-analysis
www.annallergy.org
October 16, 2025 at 2:05 PM
Now this is a must read if you care about respiratory viruses (well RSV and HRV- the “usual suspects”). Awesome authors in a fantastic journal. Read Annals of Allergy, Asthma & Immunology today!
Two respiratory viruses associated with most recurrent wheeze and asthma development are respiratory syncytial virus (RSV) and rhinovirus (RV). This review evaluates the roles these 2 viruses play in the development of wheeze and asthma. https://loom.ly/hDm2aaI
The usual suspects
Respiratory syncytial virus and rhinovirus drive asthma development and exacerbation
www.annallergy.org
October 15, 2025 at 2:57 AM
Reposted by Mitchell Grayson, MD
Come to this years American College of Allergy, Asthma & Immunology meeting - it is going to be great! I'll be there presenting the best from Annals from the last year. Hope to see you in Orlando! (register at annualmeeting.acaai.org/2025 )
@annalsacaai.bsky.social #ACAAI25
October 8, 2025 at 3:47 PM
Reposted by Mitchell Grayson, MD
Who's this year's winner of the "Pathy" award? (wink, wink) Who was nominated? Who won? Find out in Marginal Zone, only in Annals of Allergy, Asthma & Immunology. https://loom.ly/vx0R1C8
“And the Pathy goes to…”
Erin L. Reigh, MD, MS
www.annallergy.org
October 9, 2025 at 2:04 PM
Looking forward to a great ACAAI annual meeting - come hear about the best of the best in the Annals of Allergy, Asthma & Immunology, as well as the other great talks. It is going to be a great update on Allergy and Immunology! @annalsacaai.bsky.social #ACAAI25
October 8, 2025 at 3:45 PM
Reposted by Mitchell Grayson, MD
Asthma disproportionately affects non–English-speaking populations, with language barriers contributing to worse health outcomes, including increased emergency department visits and hospitalizations. Find out what health systems can do to reduce disparities. https://loom.ly/oUepsUM
Impact of language barriers on pulmonary function and asthma control
Language barriers significantly impact asthma management
www.annallergy.org
October 7, 2025 at 2:05 PM
Reposted by Mitchell Grayson, MD
Student health center or clinic administration of subcutaneous immunotherapy (SCIT) while at college/university is not well studied. This study aimed to clarify SCIT administration on campus both from the Allergist’s and student health center's perspectives. https://loom.ly/7DZZCHM
Subcutaneous immunotherapy administration on college campuses
Two exploratory surveys of Florida allergists and student health
www.annallergy.org
October 2, 2025 at 2:05 PM
Reposted by Mitchell Grayson, MD
This study hoped to better understand the experiences of college students with and without food allergy (FA) to determine ways to improve safety and quality of life for those with FA. Were they successful? Find out: https://loom.ly/LRKese4
Determining avenues for improved food allergy support and safety on college campuses
Food Allergy (FA) is a chronic disease with public health importance affecting an estimated 1 in 13 children and 1 in 10 adults.
www.annallergy.org
September 30, 2025 at 2:05 PM
Reposted by Mitchell Grayson, MD
Childhood asthma is more common in boys; however, its prevalence decreases more significantly in boys than in girls during puberty. Sex differences in urinary mast cell mediators remain unreported despite known sex-specific variations in eicosanoid pathways. https://loom.ly/exA7i_g
Sex differences in urinary mast cell mediators
Implications for diagnosing atopic and mast cell disorders
www.annallergy.org
September 25, 2025 at 2:05 PM
Did anyone catch the new Masterpiece Theatre show, “The Madness of King Donald”? Spot on! Really loved the episode at the UN.
September 24, 2025 at 12:24 PM
Reposted by Mitchell Grayson, MD
Other viruses beyond respiratory syncytial virus (RSV) and rhinovirus play a significant but underappreciated role in asthma inception and exacerbations. Learn more about these other respiratory bandits and earn CME: https://loom.ly/Dj3KirY
Beyond respiratory syncytial virus and rhinovirus
The other viral respiratory bandits
www.annallergy.org
September 23, 2025 at 2:05 PM